ADMA CIK: 1368514

ADMA Biologics, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
1.17
FY22:
35.3
FY23:
88.9
FY24:
220
FY25:
293
(positive)
Change from FY21 to FY25
millions USD
FY21:
−58.4
FY22:
−39.4
FY23:
21.6
FY24:
139
FY25:
191
(positive)
Change from FY21 to FY25
millions USD
FY21:
−53.1
FY22:
−32.8
FY23:
31.3
FY24:
149
FY25:
201
(positive)
Change from FY21 to FY25
millions USD
FY21:
−71.6
FY22:
−65.9
FY23:
−28.2
FY24:
126
FY25:
183
(positive)
Change from FY21 to FY25
millions USD
FY21:
−71.6
FY22:
−65.9
FY23:
−28.2
FY24:
198
FY25:
147

All amounts in millions USD Data sources:SEC EDGARTwelve Data